Free · no account · quoted from the filing

What changed in SYK's 10-Q

Source: 10-Q filed 2026-05-11 · compared against 10-Q 2025-10-31. Every passage below is quoted verbatim from the filing itself.

Segments

This filing

Our new Ortho Tech business combines the orthopaedic instruments portfolio (Orthopaedic Instruments) from Instruments with Other Orthopaedics.

Demand

This filing

net sales increased 2.6% in the three months 2026 as reported and 1.0% in constant currency

Margins

This filing

adjusted operating income margin (1) contracted by 180 basis points to 21.1%

Risk factors

This filing

In the first quarter 2026 we identified a cybersecurity incident which caused disruptions to our business operations.

Guidance

This filing

adjusted net earnings per diluted share (1) of $2.60 , a decrease of 8.5% from 2025

Liquidity

This filing

contract liabilities of $ 1,035 and $ 1,024 on March 31, 2026 and December 31, 2025

What it means — the analyst reading

The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel — is part of the Filing Change Monitor.

See the Filing Change Monitor →

Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.